Briagen Observational Study
- Conditions
- Mohs Surgery
- Registration Number
- NCT04090970
- Lead Sponsor
- Gemstone Biotherapeutics
- Brief Summary
This research study is evaluating a study product called Briagen™ as a possible treatment for wound healing after Mohs procedure.
- Detailed Description
Briagen, the study product being used in this study, is a natural complex carbohydrate wound dressing for skin wounds created by Mohs surgery.
Briagen was developed with the intent to improve healing time and reduce scarring of skin wounds. Briagen seeks to match the mechanical aspects of your skin (thickness, stiffness, hydration, pore size) to assist in the healing process.
The purpose of this research study is to observe healing time of Briagen applied to wounds created as a result of Mohs surgery.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- Patient seeking treatment for wound created by Mohs or other full thickness skin excisions
- Over 18 years of age
- English-speaking
- Presents for treatment within 24 hours of initial Mohs skin excision procedure.
- History of significant wound complications and non-compliance on wound maintenance instructions (infections, disturbing the wound during the healing process, etc.)
- Known diagnosis of Diabetes
- Active infection in the wound bed
- Under 18 years of age
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Healing Time 28 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Dr. David Abramson
🇺🇸Englewood, New Jersey, United States
Dermatology, Laser & Vein Specialists of the Carolinas
🇺🇸Charlotte, North Carolina, United States